FDA-Approved Biosimilar Products

Please click the links below to download PDF versions of the following documents:

This is not an offer for sale. AMJEVITA™ is currently not available commercially and will not be commercially available in the United States until on or after January 31, 2023.

Information for Healthcare Professionals

Healthcare professionals can visit www.amgenmedinfo.com, call the Amgen Medical Information hotline (800-77-AMGEN), or email medinfo@amgen.com to request medical information and to report an adverse event or product complaint.

Information for Patients

Click the button below to sign up to receive updates about Amgen Biosimilars. To learn more about what biosimilars are, visit our page for patient education on biosimilars.

FDA-Approved Biosimilar Products

Information for Healthcare Professionals

Information for Patients

Patient Form

1. Personal Information

2. Contact Information

3. Privacy and Consent

Thank You For Signing Up